Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2020.11.29.401984: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The work was approved from the Institute Biosafety Committee and Review Committee on Genetic Manipulation (RCGM), Department of Biotechnology, Government of India (No. BT/BS/17/436/2011-PID).
Consent: Human serumfrom a COVID-19 confirmed patientwascollected at 2 weeks following recovery and obtained after due consent from the patient. 2.4.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources eIF4E monoclonal antibody (5D11) and Phospho-eIF4E (Ser209) polyclonal antibodies were received from Invitrogen (South San … SciScore for 10.1101/2020.11.29.401984: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The work was approved from the Institute Biosafety Committee and Review Committee on Genetic Manipulation (RCGM), Department of Biotechnology, Government of India (No. BT/BS/17/436/2011-PID).
Consent: Human serumfrom a COVID-19 confirmed patientwascollected at 2 weeks following recovery and obtained after due consent from the patient. 2.4.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources eIF4E monoclonal antibody (5D11) and Phospho-eIF4E (Ser209) polyclonal antibodies were received from Invitrogen (South San Francisco, CA, USA) Ser209suggested: NoneGlyceraldehyde 3-phosphate dehydrogenase, house-keeping control protein) primary antibody, Anti-Mouse IgG (whole molecule)−Alkaline Phosphatase antibody (produced in goat) and Anti-Rabbit IgG (whole molecule)–Peroxidase antibody (produced in goat) were received from Sigma-Aldrich (St. Louis, USA) Glyceraldehyde 3-phosphate dehydrogenase , house-keeping control proteinsuggested: NoneAnti-Mouse IgGsuggested: NoneAnti-Rabbit IgG ( whole molecule)–Peroxidasesuggested: NoneThe clarified cell lysateswere mixed with 10 units of RiboLock RNase Inhibitor (Thermo Scientific, USA) and then incubated with the phospho-eIF4E antibody (reactive antibody),phospho ERK antibody (nonreactive antibody) or equivalent volume of IP buffer (beads control) for 45 minutes at room temperature. phospho-eIF4Esuggested: NoneExperimental Models: Cell Lines Sentences Resources Briefly, Vero cells, in triplicates were infected with SARS-CoV-2 at MOI of 5. Verosuggested: CLS Cat# 605372/p622_VERO, RRID:CVCL_0059)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
